rs1935949 — FOXO3

Second independent FOXO3 longevity signal tagging a distinct intronic haplotype block with centenarian enrichment across Caucasian populations

See your personal result for FOXO3

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

FOXO3's Second Longevity Signal — A Distinct Regulatory Haplotype

FOXO3 is one of only two human genes — along with APOE — whose longevity associations have been consistently replicated across multiple independent populations and ancestries. The first FOXO3 signal, rs280229211 rs2802292
the well-characterized HSF1-binding enhancer variant in intron 2, has been studied intensively since 2008. But FOXO3's longevity architecture is more complex: rs1935949 tags a second, independent haplotype block spanning 121 kilobases of FOXO3 intron 3 that independently contributes to centenarian enrichment through a distinct regulatory mechanism.

Pawlikowska et al. 200922 Pawlikowska et al. 2009
Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell. 2009 identified rs1935949 among longevity-associated variants across three Caucasian cohorts — the Study of Osteoporotic Fractures, the Cardiovascular Health Study, and Ashkenazi Jewish Centenarians — finding a significant longevity association in women (OR = 1.35, 95% CI 1.15–1.57, adjusted p = 0.0093).

The Mechanism

rs1935949 sits in intron 3 of FOXO3, approximately 1.7 kilobase-pairs from an intron-exon boundary, and is in strong linkage disequilibrium (r² = 0.96) with rs4946935 — the functionally characterized variant in the same haplotype block. Flachsbart et al. 201733 Flachsbart et al. 2017
Identification and characterization of two functional variants in the human longevity gene FOXO3. Nat Commun. 2017 demonstrated that the longevity allele of rs4946935 creates an allele-dependent binding site for serum response factor (SRF) — a transcription factor distinct from the heat shock factor 1 (HSF1) that binds the rs2802292 site. In luciferase reporter assays, the longevity alleles at rs4946935 (and by proxy, rs1935949) show substantial enhancer activity that is specifically reversed by IGF-1 treatment.

This IGF-1 reversibility is mechanistically significant. The insulin/IGF-1 signaling (IIS) pathway44 insulin/IGF-1 signaling (IIS) pathway
the PI3K-AKT cascade that phosphorylates and excludes FOXO3 from the nucleus is the primary evolutionary brake on FOXO3 activity: high IGF-1 levels drive AKT activation, which phosphorylates FOXO3 and traps it in the cytoplasm, preventing it from activating stress-response and longevity genes. The longevity allele at rs1935949's haplotype creates an enhancer that is most active when IGF-1 is low — exactly the dietary and metabolic condition under which FOXO3's protective functions matter most. This explains why the variant was first identified in a study of IGF-1 signaling pathway genetics and why its effects are magnified by caloric restriction and fasting contexts.

An eQTL database search confirms that the longevity alleles associated with the rs1935949/rs4946935 haplotype block are associated with higher FOXO3 mRNA expression across multiple human tissues, consistent with the enhancer model. The haplotype containing rs1935949 (haplotype block 1, alongside rs13217795, rs2764264, rs9400239, and rs9486902, D'>0.86 spanning 121 kb) is structurally distinct55 structurally distinct
the haplotype blocks were identified by LD analysis across 12 FOXO3 SNPs from the block containing rs2802292, allowing independent additive effects on longevity.

The Evidence

Bao et al. 201466 Bao et al. 2014
Association between FOXO3A gene polymorphisms and human longevity: a meta-analysis. Asian J Androl. 2014 pooled five of its eleven studies that genotyped rs1935949, encompassing 1,435 cases and 2,098 controls, finding significant overall longevity association (OR = 1.14, 95% CI 1.01–1.27). Gender-stratified results suggested the overall association was not driven primarily by females in this cohort, though the sex-specific picture is complex and differs across studies.

The largest replication effort comes from Bae et al. 201877 Bae et al. 2018
Effects of FOXO3 polymorphisms on survival to extreme longevity in four centenarian studies. J Gerontol A Biol Sci Med Sci. 2018, which analyzed 2,072 cases and 6,194 controls across the Long Life Family Study, New England Centenarian Study, Southern Italian Centenarian Study, and Longevity Genes Project. rs1935949 showed a meta-analysis beta of 0.18 (SE 0.044, p = 6.60×10⁻⁵), corresponding to approximately OR = 1.20 for extreme longevity (defined as surviving to the oldest 1 percentile of the 1900 U.S. birth cohort — ≥96 years for males, ≥100 for females). Centenarian enrichment of the protective A allele was observed in all four cohorts, though effect sizes varied.

Evidence is strongest in Caucasian populations. Studies in Chinese Han populations did not replicate the rs1935949 association, consistent with population-specific LD patterns and potentially different regulatory architectures across ancestries.

Practical Implications

The IGF-1-reversible nature of this haplotype's regulatory effect suggests a dietary angle that is more explicit than for rs2802292. Dietary interventions that lower circulating IGF-1 — particularly plant-protein-predominant diets and periodic fasting — reduce IGF-1-mediated suppression of FOXO3 at this enhancer. Caloric restriction extending maximum lifespan in model organisms is mechanistically connected to reduced IIS signaling and consequent FOXO3 activation; the rs1935949 haplotype may amplify this response.

The additive architecture of FOXO3 longevity signals is worth appreciating. Individuals who carry protective alleles at both rs1935949 and rs2802292 benefit from independent contributions to FOXO3 expression through distinct transcription factor binding sites (SRF at the rs4946935/rs1935949 haplotype; HSF1 at rs2802292). The two mechanisms respond to different cellular stresses — nutrient status for the IGF-1-sensitive haplotype, heat shock and oxidative stress for the HSF1 site — making them genuinely complementary.

Interactions

rs1935949 and rs2802292 are in different haplotype blocks across FOXO3 and have independent longevity effects. Individuals carrying protective alleles at both loci likely experience additive longevity benefit through distinct molecular mechanisms (SRF-mediated nutrient-sensing regulation vs. HSF1-mediated stress response regulation). A compound action is worth considering for individuals carrying beneficial alleles at both rsids, as the combined message — targeting both IGF-1 reduction and stress-response activation — is more specific than either alone.

rs4946935 (r² = 0.96 with rs1935949) is the functional proxy variant for the enhancer mechanism; individuals who have both in their genome data will likely have concordant results. rs13217795, also in haplotype block 1, has been separately shown to regulate an alternative FOXO3 promoter (FOXO3-TR isoform expression), adding another regulatory dimension to the same haplotype block.

Genotype Interpretations

What each possible genotype means for this variant.

GG Common Non-Protective Genotype Normal

Two copies of the reference G allele — no rs1935949 longevity enhancement

The GG genotype means neither copy of your FOXO3 gene has the intron 3 enhancer sequence created by the A allele. Your FOXO3 expression will not receive the SRF-mediated boost during low-IGF-1 states that A-allele carriers enjoy. FOXO3 is still expressed and functional in GG individuals — this variant modifies regulatory enhancement rather than eliminating gene function.

The centenarian enrichment data (Bae et al. 2018 across four cohorts) consistently show higher A-allele frequency in centenarians than controls. GG individuals have the lowest centenarian enrichment, though many centenarians carry the GG genotype — the variant is a statistical modifier, not a deterministic gate.

The good news: FOXO3 activation remains highly responsive to lifestyle regardless of rs1935949 genotype. Caloric restriction, fasting, high-intensity exercise, and cold exposure all activate FOXO3 through mechanisms that don't require the intron 3 SRF enhancer. GG individuals who engage these practices vigorously can achieve FOXO3 activation levels that rival sedentary A-allele carriers.

AG One Longevity Allele Beneficial

One copy of the protective A allele — meaningful centenarian enrichment with intermediate effect

With one A allele, you have partial activation of the FOXO3 intron 3 regulatory haplotype. The single functional SRF binding site on your A-allele copy responds to low-IGF-1 conditions to drive FOXO3 transcription, while your G-allele copy lacks this site. The heterozygous effect is intermediate between the protective AA and non-protective GG genotype, following the additive architecture observed across all four centenarian cohorts in Bae et al. 2018.

The SRF-mediated enhancer mechanism at this haplotype is distinct from and additive with the HSF1-mediated stress-response mechanism at the other major FOXO3 longevity locus: different transcription factors boost FOXO3 expression under different cellular stress conditions, providing complementary and additive longevity benefit.

AA Dual Longevity Alleles Beneficial

Two copies of the longevity-associated A allele — maximum centenarian haplotype enrichment

With two copies of the A allele, both copies of your FOXO3 gene carry the longevity-associated haplotype centered on this locus. Each copy creates a serum response factor (SRF) binding site in the intron 3 enhancer region; when circulating IGF-1 is low (during fasting, caloric restriction, or plant-predominant eating), this enhancer becomes fully active and drives increased FOXO3 transcription.

The effect is genuinely additive: the centenarian studies consistently show dose-response effects where AA individuals have higher longevity odds than AG individuals, who in turn have higher odds than GG individuals. In the Bae et al. 2018 four-cohort meta-analysis, the log-odds scale beta of 0.18 per allele translates to approximately OR = 1.20 per copy — so AA individuals enjoy roughly 1.44-fold higher odds of extreme longevity compared to GG individuals, beyond the benefit from other FOXO3 variants.

This variant is in strong LD (r² = 0.96) with a functionally characterized nearby variant, and the two likely report the same regulatory signal. The SRF-mediated enhancer mechanism at this haplotype is distinct from and additive with the HSF1-mediated stress-response mechanism at the other major FOXO3 longevity locus, providing complementary regulatory amplification.